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Background and aims: Overproduction of nitric oxide via inducible nitric oxide synthase (iNOS) is
suggested to be a significant pathogenic factor in Helicobacter pylori induced gastritis. The purpose of this
study was to examine the role of iNOS in H pylori associated gastric carcinogenesis.
Methods: Two types of mice were used in this study: iNOS deficient mice (iNOS2/2) and wild-type
littermates. Gastric cancer was generated in mice using a combination treatment comprising N-methyl-N-
nitrosourea administration and H pylori infection. Fifty weeks after treatment, tumours in gastric tissues
from both types of mice were examined using histopathology, immunohistochemistry, and immunoblotting
for iNOS and 3-nitrotyrosine.
Results: The overall incidence of gastric cancer at week 50 was significantly lower in iNOS2/2 compared
with iNOS wild-type mice (p,0.05). When analysed according to tumour pathology, the incidence of
gastric adenocarcinoma was significantly lower in iNOS2/2 compared with iNOS wild-type mice
(p,0.05). Immunostaining for iNOS was clearly observed in adenocarcinoma cells of iNOS wild-type
mice, and was characterised by a strong cytoplasmic expression pattern. 3-Nitrotyrosine was expressed
mostly in the area of the lamina propria of gastritis and adenoma lesions in iNOS wild-type mice.
Immunoblotting analyses showed that iNOS and 3-nitrotyrosine were also expressed in both adenoma
and adenocarcinoma tissues from iNOS wild-type mice. iNOS and 3-nitrotyrosine expression was greater
in tumour tissues than in non-tumour tissues.
Conclusions: These findings suggest that iNOS contributes to H pylori associated gastric carcinogenesis in
mice.
G
astric adenocarcinoma is one of the most prevalent
malignant neoplasms worldwide, particularly in
Eastern Asia, including Korea and Japan.1 2 Deve-
lopment of gastric cancer is believed to occur over a long
period of time and to involve a number of events, with the
primary aetiological determinants being exposure to chemical
carcinogens and/or Helicobacter pylori infection.3 H pylori is the
most important aetiological agent of chronic active gastritis
and peptic ulcers. Moreover, H pylori infection has been
identified as a human carcinogen based mainly on epide-
miological evidence,4 and it is possible that chronic inflam-
mation induced by H pylori infection increases the risk of
gastric cancer.
It has been proposed that formation of reactive oxygen
species (ROS) as a result of neutrophil infiltration in response
to H pylori infection can injure epithelial cells and damage
their DNA, which may contribute to the initiation and
promotion of tumours. Apart from ROS, another important
mediator in chronic inflammatory processes after H pylori
infection is nitric oxide (NO), which is produced by gastric
epithelial and non-epithelial cells from L-arginine via a family
of three distinct nitric oxide synthase (NOS) isoforms.5 6 Two
NOS isoforms are constitutively expressed and are calcium
dependent—namely, eNOS (expressed in vascular endothe-
lial cells) and nNOS (expressed in neurones of the central
and peripheral nervous system). The third isoform, iNOS, is
inducible and calcium independent, and is expressed in
response to bacterial endotoxins and cytokines to cause
sustained NO release. iNOS can produce larger amounts of
NO than either eNOS or nNOS. NO overproduction is
associated with the pathogenesis of a variety of disorders
including cancer, and NO also stimulates tumour angio-
genesis7 as well as vascular permeability in solid tumours.8
Increased iNOS activity has been observed in patients with
chronic gastritis and precancerous lesions, as well as in
gastric adenocarcinoma patients,9 10 and it has been reported
that iNOS levels were significantly reduced after eradication
of H pylori.11 iNOS expression in the gastric mucosa is
significantly higher in H pylori positive gastric cancer patients
than in H pylori negative patients.12 These observations
suggest that overproduction of the iNOS enzyme in the
gastric mucosa infected with H pylori may contribute to the
carcinogenesis of gastric cancer. However, high induction of
iNOS with subsequent overproduction of NO involves
complex responses in tissues which has led to some debate
regarding the effect of iNOS on carcinogenesis. For example,
some studies have reported protection after inhibition of
iNOS13–15 while others have reported exacerbation of the
carcinogenic process.16 17
Advances in recombinant DNA technology have permitted
the development of mice that specifically lack the capacity to
express the iNOS gene.18 These iNOS2/2 mice can produce
NO constitutively but are unable induce NO production via
the iNOS enzyme. The aim of the present study was to
examine the role of inducible NO production in H pylori
associated gastric carcinogenesis. To achieve this we used
Abbreviations: NO, nitric oxide; NOS, NO synthase; iNOS,
inducible NOS; eNOS, endothelial NOS; nNOS, neuronal NOS; MNU,
N-methyl-N-nitrosourea; ROS, reactive oxygen species; CFU, colony
forming unit; AG, aminoguanidine
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iNOS2/2 and their wild-type littermates in a previously
published mouse model of H pylori associated gastric cancer.19
MATERIALS AND METHODS
Mice
Male C57BL/6-Nos2tm1Lau (iNOS2/2 ) mice (iNOS2/2 ) and
wild-type littermates (iNOS wild-type) were obtained from
Jackson Laboratory (Bar Harbor, Maine, USA) at five weeks
of age. Mice were handled in an accredited Korean FDA
animal facility in accordance with AAALAC International
Animal Care policies (Accredited Unit-Korea Food and Drug
Administration: Unit Number-000996). All mice were given a
standard pellet chow diet (CRF-1; Oriental Yeast Co., Ltd,
Tokyo, Japan) ad libitum and were maintained under specific
pathogen free conditions.
Chemicals and bacteria
N-methyl-N-nitrosourea (MNU) (Sigma Chemical Co., St
Louis, Missouri, USA) solutions were freshly prepared twice a
week by dissolving 200 mg/l MNU in distilled water. Where
indicated, mice were given the 200 mg/l MNU solution ad
libitum in light shielded bottles in place of drinking water.
Mouse adapted H pylori (SS1) were inoculated on Brucella
agar plates (Becton Dickinson, Cockysville, Maryland, USA)
containing 10% heat inactivated fetal bovine serum and
Skirrow medium (Difco, Detroit, Michigan, USA). They were
kept at 37 C˚ under microaerobic conditions using GasPak jars
(Difco) and CampyPaks (Becton Dickinson). After 24 hours
of fasting, a 0.1 ml suspension of H pylori containing 16109
colony forming units (CFU)/ml was administered by intra-
gastric intubation.
Study design
Mice were divided randomly into two groups (fig 1). Both
iNOS wild-type (n=25) and iNOS2/2 (n=30) mice were
given drinking water containing MNU (200 mg/l) every
second week for 10 weeks. One week after completing
MNU treatment, both iNOS2/2 and iNOS wild-type mice
were inoculated with H pylori three times every other day.
Mice were sacrificed 38 weeks after the first inoculation with
H pylori.
Histopathological examination
Immediately after sacrifice, mouse stomachs were opened
along the greater curvature. The number as well as the length
(diameter) of the tumours in the stomach were measured. A
record was kept of the size and number of tumours counted,
with a diagnosis being made after the final histopathological
examination. The excised stomachs were fixed in neutral
buffered 10% formalin and cut into approximately six strips,
processed by standard methods, embedded in paraffin,
sectioned at 4 mm, and stained with haematoxylin and eosin.
Histopathological examination was used to classify the
characteristics of the tumours based on both the histopatho-
logical and cytological criteria reported by Leininger and
Jokinen.20 After diagnosing the tumour, tumour incidence
and multiplicity were calculated. Samples of tumours and
normal stomach tissue were quickly frozen in liquid nitrogen
for western blot analyses.
Identification of H pylori in gastric mucosa
To confirm H pylori infection, approximately 3 mm2 samples
of stomach mucosa from the greater curvature containing
both fundic and pyloric glands were transferred to 1.0 ml of
sterile 0.1 M phosphate buffered saline, homogenised, and
plated on selective trypticase soy agar/5% sheep blood plates
containing vancomycin (20 mg/ml), nalidixic acid (10 mg/
ml), bacitracin (30 mg/ml), and amphotericin B (2 mg/ml)
(Sigma Chemical Co.), and grown for 3–5 days. Colonies
were identified by characteristic Gram stain morphology, and
by urease, catalase, and oxidase activity. Another 3 mm2
sample from the antrum was placed into the gel of a rapid
urease test kit (CLO test; Trimed, Delta West, Australia) and
left for six hours at room temperature to test for urease
activity. The presence of H pylori in the gastric pit was further
confirmed by Warthin-Starry staining.
iNOS and 3-nitrotyrosine immunohistochemistry
Immunohistochemical identification of iNOS and 3-
nitrotyrosine protein expression was performed on replicate
sections of stomach tissues. Sections were mounted on
siliconised slides (Dako, Denmark), dewaxed, rehydrated,
and endogenous peroxidase activity quenched using hydro-
gen peroxide (3% v/v). After washing in double distilled
water, sections were subjected to microwave antigen retrieval
in a 0.01 M citrate buffer, pH 6.0, for 10 minutes at 750 W.
Sections were allowed to cool and were then blocked with a
blocking serum for one hour. Slides were incubated with
either polyclonal antibody against iNOS (1:400) (Cayman
Chemical, Michigan, USA) or monoclonal antibody against 3-
nitrotyrosine (1:50) (Upstate Biotechnology, Lake Placid,
New York, USA) overnight at 4 C˚. Immunoreaction com-
plexes were detected using the avidin-biotin affinity system
(Santa Cruz Biotechnology, California, USA) and visualised
with 3,3-diaminobenzidine tetrahydrochloride as the chro-
mogen. Sections were counterstained with Mayer’s haema-
toxylin and examined under a light microscope. ‘‘Control’’
sections were produced by excluding iNOS or 3-nitrotyrosine
antibodies during analysis.
Western blotting for iNOS and 3-nitrotyrosine
Frozen tissue regions from the glandular stomach diagnosed
as non-tumour, adenoma, or adenocarcinoma were separ-
ately homogenised in RIPA buffer (10 mM Tris (pH 7.6),
1 mM EDTA (pH 8.0), 100 mM NaCl, 1 mg/Me aprotinin, and
100 mg/Me PMSF (all from Sigma Chemical Co.)). Protein
concentration was measured using a Bio-Rad Protein Assay
kit (Bio-Rad Laboratories, Hercules, California, USA).
Extracted proteins (40 mg/lane) were resolved by sodium
dodecyl sulphate-polyacrylamide gel electrophoresis and
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Figure 1 Study design. Mice were randomised to one of two groups and treated with N-methyl-N-nitrosourea (MNU) plus Helicobacter pylori. Group
1=wild-type littermates (C57BL/6 background); group 2= iNOS2/2 .
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transferred to PVDF membranes. Membranes were incubated
overnight at 4 C˚ with either an iNOS polyclonal antibody
(1:500) or a 3-nitrotyrosine monoclonal antibody (1:1000),
and then incubated for 45 minutes with a secondary
antibody (Santa Cruz). Following incubation with the
secondary antibody, blots were washed three times with
phosphate buffered saline/0.1% Tween-20 and deve-
loped with a commercial chemiluminescence detection
kit (Amersham Biosciences UK Ltd, Little Chalfont,
Buckinghamshire, UK). Protein expression was quantified
using a Bio-Rad Imaging Densitometer system Model GS690
(Bio-Rad Laboratories).
Statistical analysis
Data were analysed using the JMP software package (version
4.0) (SAS Institute, Cary, North Carolina, USA) on an IBM
computer. Stomach tumour incidence data were analysed
using a x2 test. Other data were compared using the Dunnett
t test after ANOVA analysis. For all comparisons, probability
values less than 5% (p,0.05) were considered statistically
significant.
RESULTS
Bacterial colonisation
At week 50, stomachs were removed and all mice from both
groups showed positive H pylori colonisation, as determined
by direct bacterial culture and rapid urease tests. The mean
(SEM) number of CFU recovered from mice inoculated orally
with H pylori SS1 was 2.32 (0.21)6105/mg gastric tissue.
Warthin-Starry staining showed numerous spiral bacteria in
gastric cells along the length of the gastric pits in both the
antrum and body of all animals inoculated with H pylori.
Incidence and multiplicity of stomach tumours
Tumour incidence and multiplicities are summarised in
table 1. The body weight of iNOS wild-type and iNOS2/2
mice was similar throughout all experiments. Tumours were
found mostly in the pyloric mucosa adjacent to the fundic
region. Macroscopically, most tumours showed a polypoid
growth pattern similar to type I stomach cancers in humans
(fig 2), and some were sessile. Tumour incidences at week 50
were 72.7% (16/22) and 31.0% (9/29) in iNOS wild-type and
iNOS2/2 mice, respectively, and this difference was statis-
tically significant (p,0.05).
There were significant differences in tumour pathologies
between the two types of mice. In wild-type mice, gastric
adenomas constituted 27.3% and adenocarcinoma 45.5% of
all tumours, while in iNOS2/2 mice the incidence of gastric
adenoma and adenocarcinoma was 10.3% and 20.7%,
respectively. Collectively, the incidence of gastric adenocarci-
nomas was significantly lower in iNOS2/2 mice compared
with iNOS wild-type mice (table 2). These findings strongly
suggest that the absence of iNOS significantly suppresses
chemical carcinogen and H pylori associated gastric carcino-
genesis in mice.
iNOS and 3-nitrotyrosine protein expression in
stomach tissue
iNOS protein expression was independently evaluated by
three pathologists using immunohistochemical techniques.
As expected, there was no iNOS detected in epithelial or
stromal cells of gastric mucosal tissue from iNOS2/2 mice.
In contrast, iNOS was strongly expressed in the cytoplasm of
adenocarcinoma cells from iNOS wild-type mice, especially in
cells on the luminal side (fig 3A). Elsewhere, iNOS
expression in adenocarcinomas of wild-type mice was limited
to small numbers of fibroblasts and inflammatory cells that
had infiltrated the stroma (fig 3B).
Immunohistochemical analysis was also performed in
order to determine 3-nitrotyrosine expression. 3-Nitro-
tyrosine was found to be strongly expressed in the cytoplasm
of infiltrating chronic inflammatory cells such as macro-
phages, some lymphocytes, and some fibroblasts in tissues
from iNOS wild-type mice with gastritis and adenomas
(fig 4). In contrast, 3-nitrotyrosine was not detectable in such
cells in tissue from iNOS2/2mice. Negative controls showed
no positive immunoexpression in tissue sections when the
primary antibody step was omitted.
Table 1 Incidence and multiplicities of glandular stomach tumours in mice
Group
Total No
of mice
Effective No
of mice
No of
dead (%)
No of tumour bearing
mice (% incidence)
Tumour
multiplicity
1= iNOS wild-type 25 22 3 (12) 16 (72.7) 1.25 (0.14)
2 = iNOS2/2 30 29 1 (3.3) 9 (31.0)* 1.25 (0.11)
Values are mean (SEM).
*Significantly different from group 1 (p,0.05).
Figure 2 Macroscopic (A) and microscopic (B, C) appearance of gastric cancers in wild-type mice. (A) Multiple polypoid tumours are evident in the
stomachs of inducible nitric oxide synthase (iNOS) wild-type mice after N-methyl-N-nitrosourea and Helicobacter pylori treatment. (B) The polypoid
mass shows an intramucosal adenocarcinoma with disseminated neoplastic glandular formations (original magnification6100). (C) The adeno-
carcinoma shows an atypical irregular glandular hyperplasia with cribriform appearance, which is composed of pleomorphic atypical tumour cells with
oval to round nuclei, with many mitotic figures apparent (arrow) (original magnification6400).
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Western blotting using gastric mucosa homogenates was
performed in order to quantitatively analyse iNOS and
3-nitrotyrosine levels in non-tumour and tumour (adenoma
and adenocarcinoma) tissue from wild-type mice. We found
that both proteins were expressed in homogenates derived
from non-tumour, adenoma, and adenocarcinoma tissue
(fig 5A). However, iNOS expression was significantly higher
in adenoma and adenocarcinoma tissues compared with non-
tumour tissues (p,0.05) (fig 5B). Similarly, 3-nitrotyrosine
protein expression was significantly higher in adenoma and
adenocarcinoma homogenates compared with non-tumour
homogenates (p,0.05) (fig 5C).
DISCUSSION
The major purpose of this study was to better understand
the influence of iNOS expression on the development of
H pylori associated gastric cancer. To achieve this aim, we
used iNOS gene deficient mice and wild-type littermates
in a mouse model of MNU and H pylori induced gastric
cancer formation. We found that lack of iNOS significantly
lowered the incidence of H pylori associated gastric cancer.
These data suggest chronic iNOS overexpression and con-
sequent NO overproduction may principally contribute to
H pylori induced gastric carcinogenesis. These observations
suggest that amelioration of NO production might be a
Table 2 Incidence of glandular stomach tumours according to histopathological findings
Group
Effective No of
mice
No of tumour
bearing mice
Gastric
adenoma (%)
Gastric
adenocarcinoma (%)
1= iNOS wild-type 22 16 6 (27.3) 10 (45.5)
2 = iNOS2/2 29 13 3 (10.3) 6 (20.7)*
*Significantly different from group 1 (p,0.05).
Figure 3 Immunohistochemical staining for inducible nitric oxide
synthase (iNOS) in adenocarcinomas of wild-type mice. (A) Positive
staining for iNOS was clearly observed in iNOS wild-type adeno-
carcinoma epithelial cells which was characterised by a strong intense
cytoplasmic expression pattern. Epithelial staining was particularly
strong on the luminal surfaces (arrow) of the carcinoma cells (original
magnification6200). (B) iNOS immunoreactivity in adenocarcinoma of
wild-type mice was also occasionally observed in inflammatory cells
(arrow) in the stroma (original magnification6200).
Figure 4 Immunohistochemical staining for 3-nitrotyrosine in inducible
nitric oxide synthase (iNOS) wild-type mice with gastritis (A) and
adenoma (B). (A) 3-Nitrotyrosine protein was located primarily in the
cytoplasm of inflammatory cells such as macrophages (arrow) and some
fibroblasts (arrowhead) in the area of foveolar epithelial hyperplasia
(original magnification6200). (B) 3-Nitrotyrosine protein was located
primarily in the cytoplasm of fibroblasts (arrow) in the area of the lamina
propria of adenoma lesions (original magnification6200).
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feasible chemoprevention strategy for H pylori associated
gastric carcinogenesis.
Chronic inflammation provides a microenvironment that
can drive tumorigenesis.5 21 The incidence of gastric cancer
has been mechanistically and clinically associated with
H pylori infection induced chronic gastritis. Recent studies12 22
have revealed that H pylori infection in humans is associated
with enhanced expression of iNOS by tissue neutrophils and
mononuclear cells, and that NO and its products are key
molecules in H pylori pathophysiology. There has been
accumulating evidence that high levels of NO sustained over
extended periods of time contribute to carcinogenesis.
The toxicity of NO has been attributed to the potent
nitrating and oxidising agent, peroxynitrite, which is formed
by a near diffusion limited reaction between NO and
superoxide. Peroxynitrite has been shown to induce DNA
strand breaks, provoke nitration and oxidation of proteins
and nucleic acids, and drive cell death in vitro.23 24 As there is
no suitable method to directly detect peroxynitrite formation
in vivo, its reaction product, 3-nitrotyrosine, is measured as a
marker of peroxynitrite production. This product has been
detected immunohistochemically in acute lung injury in
humans and rats,25 and in liver tumours.26
In the present study, expression and location of
3-nitrotyrosine were investigated immunohistochemically
in H pylori associated gastric tumours. It was anticipated
that absence of iNOS would lower peroxynitrite levels,
and consistent with this, we observed positive staining
for 3-nitrotyrosine only in tissue from wild-type mice.
3-Nitrotyrosine in stomach tumours was localised primarily
in stromal cells with no detectable staining of the epithelium,
which was characterised by a strong intense cytoplasmic
staining pattern. 3-Nitrotyrosine positive cells (most likely
inflammatory cells) were observed in mesenchymal tissues of
gastritis and gastric adenoma samples, and were also
observed in cells of venules and arterioles. These results are
consistent with those of Goto and colleagues12 who observed
nitrotyrosine in inflammatory cells and the extracellular
matrix of human gastric cancer samples. Epithelial staining
and intense staining in areas of intestinal metaplasia were
consistent with epithelial localisation of iNOS in human
H pylori gastritis27 and inflammatory bowel disease.28 The
present study demonstrated that iNOS is expressed princi-
pally in epithelial cells of adenocarcinoma tissues. Epithelial
staining was particularly strong in glands exhibiting intes-
tinal metaplasia. Quantitative analysis of iNOS and
3-nitrotyrosine expression in wild-type mice showed adenoma
tissues had the highest levels of iNOS and 3-nitrotyrosine
compared with non-tumour and adenocarcinoma tissue.
These data suggest that iNOS and 3-nitrotyrosine may play
an important role in the early stage initiation of gastric
carcinogenesis.
Chronic inflammatory diseases of the gastrointestinal tract
thought to precede cancer include Barrett’s oesophagus,
ulcerative colitis, and H pylori associated gastritis, and all are
associated with increased iNOS expression and considerable
nitrosative stress.5 28 These observations suggest chronic
overexpression of iNOS, and the associated NO overproduc-
tion may contribute to tumorigenesis, making this process an
attractive target for chemoprevention strategies. iNOS2/2
mice are reported to have a significant resistance to lethality,
and show attenuated colonic damage and reduced nitrotyr-
osine formation and malondialdehyde concentrations in the
trinitrobenzene sulphate induced ulcerative colitis model.29
iNOS2/2mice fed dextran sodium sulphate showed reduced
signs and symptoms of colitis compared with wild-type mice,
suggesting that iNOS plays a critical role in the pathology of
colitis.30 However, the implications of this reduced inflam-
mation on the development of colon cancer in these mice has
not been shown. Ahn and Ohshima13 reported a significant
reduction in the number of adenomas in Min/iNOS2/2 mice
compared with Min (multiple intestinal neoplasia) mice,
indicating NO plays a key role in promoting colon carcino-
genesis on a background of an APC mutation. The current
study appears to be the first showing the preventive effect of
iNOS genetic ablation on H pylori associated gastric carcino-
genesis.
In contrast with our findings, some studies have shown
either no effect or even exacerbation of inflammation and
tumorigenesis following NO inhibition. In a Rhesus monkey
model, Ribbons and colleagues16 found no effect of the NO
inhibitor aminoguanidine (AG) on spontaneous colitis, and
Yoshida and colleagues17 reported that inhibition of NO
production by either 1-N(G)-nitroarginine methyl ester or AG
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Figure 5 Inducible nitric oxide synthase (iNOS) and 3-nitrotyrosine protein expression levels in tumours and non-tumour tissues in wild-type mice.
iNOS and 3-nitrotyrosine protein expression levels were determined by western blot analysis. Mean (SEM) values are shown. (A) iNOS and
3-nitrotyrosine proteins were identified in non-tumour (NT), adenoma (AD), and adenocarcinoma (AC) tissue homogenates from wild-type mice.
(B) iNOS expression was significantly higher in AD and AC compared with NT tissues (p,0.05). (C) The amount of 3-nitrotyrosine protein in AD and
AC tissue homogenates was significantly higher than that in NT tissues (*p,0.05).
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resulted in increased dextran sodium sulphate induced
inflammation, suggesting a protective role of NO in a disease
model of acute colitis. We found that administration of AG to
H pylori infected animals did not significantly decrease the
incidence of H pylori promoted gastric carcinogenesis or the
severity of H pylori associated gastritis (unpublished data).
Therefore, we inferred that AG alone did not affect the
significant attenuation of iNOS or insufficient ablation of
iNOS expression compared with the current genetic ablation.
The other possibility is that insufficient blocking or in-
appropriate blocking time of iNOS was achieved after AG
treatment, which rather blocked the beneficial role of NO in
either inflammation or carcinogenesis.
In conclusion, we found that H pylori induced gastric
tumorigenesis and NO associated nitrotyrosine formation
related to carcinogenesis was lower in mice lacking iNOS.
Therefore, lowering of iNOS derived NO levels may be an
important clinical strategy in the prevention of H pylori
associated gastric cancer.
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